KOLMAR BNH Co.,Ltd. (KOSDAQ:200130)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,190
+10 (0.08%)
Feb 21, 2025, 3:30 PM KST
-20.11%
Market Cap 384.05B
Revenue (ttm) 619.27B
Net Income (ttm) 15.86B
Shares Out 29.12M
EPS (ttm) 544.70
PE Ratio 24.22
Forward PE n/a
Dividend 308.00 (2.34%)
Ex-Dividend Date n/a
Volume 160,804
Average Volume 65,624
Open 13,260
Previous Close 13,180
Day's Range 13,070 - 13,530
52-Week Range 11,030 - 19,970
Beta 0.84
RSI 65.37
Earnings Date Mar 19, 2025

About KOLMAR BNH

Kolmar BNH Co., Ltd. engages in the research and development of materials used in the functional health food and cosmetics market in South Korea and internationally. The company offers cosmetics; and provides total functional health food original development manufacturing services, such as manufacturing tablets, hard capsules, soft capsules, liquids, gels, powder dosage, and various new formulation forms. It offers packaging products, such as PTP/multi-PTP, powder stick/pouch, three-side cloth, four-side, and liquid stick packaging; and ODM con... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2004
Employees 521
Stock Exchange KOSDAQ
Ticker Symbol 200130
Full Company Profile

Financial Performance

In 2023, KOLMAR BNH's revenue was 579.55 billion, an increase of 0.63% compared to the previous year's 575.90 billion. Earnings were 19.71 billion, a decrease of -51.35%.

Financial Statements

News

Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement

SEOUL, South Korea — Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG)...

3 months ago - Financial Post

HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA

SEOUL, South Korea — ‘HemoHim,’ an immune-boosting health supplement from Kolmar BNH (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration...

4 months ago - Financial Post